99mTc-maraciclatide

N/A

Report date: 2025/11/20 11:38:26
NME

Base Information

Drug Name99mTc-maraciclatide
Drug Alias NameNC-100692-[99mTc]99mdTc-NC-100692technetium-99m-NC-100692maraciclatide-[99mTc]Tc99m-maraciclatide +[10] 
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTc +[5] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsDiabetes MellitusAcute Coronary SyndromeHeart Failure +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGe Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSerac Healthcare LtdSerac Life Sciences LtdGe Healthcare +[4] 
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusAcute Coronary SyndromeHeart Failure +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG